NEW Zealand's Pharmaceutical Management Agency (PHARMAC) has opened a consultation relating to increased pricing and subsidisation of GSK's Habitrol brand of nicotine replacement therapy in the form of gum, lozenges and patches.
Consultation closes 5pm 04 Aug - procurement@pharmac.govt.nz.
The above article was sent to subscribers in Pharmacy Daily's issue from 25 Jul 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 25 Jul 17